Pacific Biosciences Of California (PACB) Shareholder's Equity (2010 - 2026)

Pacific Biosciences Of California (PACB) Shareholder's Equity (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 52.06 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 22.98 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 49.20 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 26.10 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 10.33 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 13.34 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 2.96 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.67 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 7.20 Bn
10 Pacific Biosciences Of California 426.62 Mn 150.66 Mn 12.84 Mn 2.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.37 Mn
Dec 31, 2025 5.35 Mn
Sep 30, 2025 36.09 Mn
Jun 30, 2025 61.49 Mn
Mar 31, 2025 91.64 Mn
Dec 31, 2024 506.59 Mn
Sep 30, 2024 453.12 Mn
Jun 30, 2024 492.70 Mn
Mar 31, 2024 649.02 Mn
Dec 31, 2023 701.30 Mn
Sep 30, 2023 763.74 Mn
Jun 30, 2023 642.00 Mn
Mar 31, 2023 692.12 Mn
Dec 31, 2022 562.90 Mn
Sep 30, 2022 626.59 Mn
Jun 30, 2022 681.89 Mn
Mar 31, 2022 734.58 Mn
Dec 31, 2021 790.99 Mn
Jun 30, 2021 258.25 Mn
Mar 31, 2021 280.55 Mn